DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Thienamycin
Thienamycin
In Vitro and in Vivo Study of Fosfomycin in Methicillin-Resistant Staphylococcus Aureus Septicaemia
Thienamycin (Imipenem)
Profile Profile Profile Uses and Administration
Radical Sam Enzymes in Thienamycin Biosynthesis
Computational Antibiotics Book
PRIMAXIN (Imipenem and Cilastatin)
The Use of Natural Product Substrates for the Synthesis of Libraries of Biologically Active, New Chemical Entities
A Thesis Entitled an Oral Dosage Form of Ceftriaxone Sodium Using Enteric
Drug Delivery System Utilizing Thermosetting Gels
Antimicrobial Agents and Chemotherapy
Author Section
Individualization of Drug Therapy Considering Pharmacokinetic and Clinical Factors
Use of Monte Carlo Simulations to Determine Optimal Carbapenem Dosing In
Cefoxitin, N-Formimidoyl Thienamycin, Clavulanic
The Infinity War: How to Cope with Carbapenem-Resistant Enterobacteriaceae
Susceptibility of Gram-Positive Cocci to Various Antibiotics, Including Cefotaxime, Moxalactam, and N-Formimidoyl Thienamycin CHARLES E
Thienamycin Is One of the Most Potent, Broad Spectrum Antibiotics Presently Known
Zac4943-2Ch105t.Pdf
Top View
State of Antibiotic Development – Staying One Step Ahead?
Parenteral Carbapenems P
588 PART 441—PENEM ANTIBIOTIC DRUGS Subpart A—Bulk Drugs
The Biosynthesis of Cis-Carbapenems and the Development of Penem Antibiotics for the Treatment of Tuberculosis
Overview and Insights Into Carbapenem Allergy
Staphylococci and Evidence for High Rates of Synergism With
B-Lactams and B-Lactamase Inhibitors: an Overview
Lactamase-Producing, Carbenicillin-Resistant Pseudomonas Aeruginosa STEPHEN B
How Does It Structurally Resemble the Penicillins? How Does It Structure Differ (3 Ways)?
Total Synthesis of the Big Four Antibiotics and Related Antibiotics
Consecutive Radical S-Adenosylmethionine Methylations Form the Ethyl Side Chain in Thienamycin Biosynthesis
Antimicrobial Agentsand Chemotherapy
Lactam Rings in Natural Products
Antibiotics in the Clinical Pipeline in 2011
(10) Patent No.: US 8232268 B2
286 Antibacterials
N=N` S N-Ch2-C-Hn J-Ch2-C-Hn S 11 N S-Ch2-C-Hn \\ / Ch-C-Hn H2
Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity
Chapter 19 - Antibacterial Agents
Supplementary Information Natural Product and Natural Product Derived Drugs in Clinical Trials
INVANZ® (Ertapenem Sodium)
Novel Prodrugs of Meropenem with Two Lipophilic Promoieties: Synthesis and Pharmacokinetics
The Biosynthetic Gene Cluster for the ß-Lactam Carbapenem
Topic 8-1 Antibacterial Agents
Mcim Ecim MALDI-TOF
Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria
Thienamycin Related Antibiotics PS-6 and PS-7, Process for Their
The Intriguing Biology and Chemistry of Fosfomycin: the Only Marketed Phosphonate Antibiotic
Response of Legionella Pneumophila to ,B-Lactam Antibiotics
APPENDIX 1: Search Strategy on Pubmed Identified
Meropenem: Laboratory and Clinical Data